3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
21
Other hematologic neoplasm
16
Plasma cell
4
Genitourinary
4
Myeloid
3
Gastrointestinal
3
Thoracic
1
Other solid neoplasm
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Brain Neoplasms
1905
Glioblastoma
1797
Glioma
1130
Central Nervous System Neoplasms
599
Astrocytoma
594
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
364
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
227
Recurrence
199
Sarcoma
184
Neoplasm Metastasis
183
Melanoma
182
Meningioma
177
Ependymoma
176
Lung Neoplasms
157
Lymphoma
134
Osteosarcoma
127
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
101
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
COVID-19
×
CNS
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts